Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2006

01-05-2006 | Brief Report

Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis

Authors: David Vañó Sanchis, Gregorio Arranz Garcia, Pablo Javier Marchena Yglesias

Published in: Clinical Rheumatology | Issue 3/2006

Login to get access

Excerpt

To the editor: Systemic sclerosis (SSc) is a generalized connective tissue disorder of unknown aetiology. The main types of SSc are diffuse cutaneous systemic sclerosis (dcSSc), limited cutaneous sclerosis systemic (lcSSc), systemic sclerosis sine scleroderma (ssSSc) and overlap syndromes [1]. The ssSSc is a rare entity, scantly reported in the scientific literature [2‐5], characterized by the absence of skin involvement. We present a case of a female diagnosed of ssSSc with pulmonary involvement. …
Literature
1.
Medsger TA Jr (1997) Systemic sclerosis (scleroderma): clinical aspects. In: Koopman WJ (ed) Arthritis and allied conditions. 13th ed. Baltimore, Williams and Wilkins, pp 1433–64
2.
Rosalia M, Lomeo MD, Richard J, Cornella MD, Stephen I, Stephen I, Scabel MD, RM Silver (1989) Progressive systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis. Am J Med 87:525–527PubMedCrossRef
3.
Slobodin G, Rosner I, Rozenbaum M, Naschitz JE, Zuckerman E, Yeshurum D (2002) Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion. Rheumatol Int 22:170–172CrossRefPubMed
4.
Agard C, Hamidou M, Meriot M, Prendki V, Grolleau JY (2002) Systemic sclerosis sine scleroderma revealed by pulmonary intersticial fibrosis. La revue de médecine inerne 23:1032–1039CrossRef
5.
Molina JF, Anaya J-M, Cabrera GE, Hoffman E, Espinoza LR (1995) Systemic sclerosis sine sclerodermia: an unusual presentation in scleroderma renal crisis. J Rheumat 22:557–560
6.
Abrams HL, Carnes WH, Eaton J (1954) Alimentary tract in disseminated scleroderma with emphasis on small bowel. Arch Intern Med 94:61–81
7.
Poormoghim H, Lucas M, Fertig N, Medsger TA (2000) Systemic sclerosis sine scleroderma. Arthritis Rheum 42:444–451CrossRef
Metadata
Title
Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis
Authors
David Vañó Sanchis
Gregorio Arranz Garcia
Pablo Javier Marchena Yglesias
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0026-z

Other articles of this Issue 3/2006

Clinical Rheumatology 3/2006 Go to the issue

Case Report

Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies

Case Report

Follicular bronchiolitis, an unusual cause of haemoptysis in giant cell arteritis

Technical Note

Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma)

Original Paper

Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity

Original Article

A novel approach of local corticosteroid injection for the treatment of carpal tunnel syndrome

Original Article

Incidence and clinical correlation of anticentromere antibody in Thai patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits